We find your cause before we target the nerve
Stem cell therapy for neuropathy in Istanbul, Turkey
Our Istanbul team diagnoses the source of your neuropathy, protects standard care, and offers a carefully monitored cell therapy option where it fits.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Evidence position
What is known, what is investigational, and what is not demonstrated
Cause-specific care, closely monitored cell option
Neuropathy is a pattern, not one disease — diabetes, toxins, medicines, immune disease, compression, and nutrition each call for different treatment.
We match the route to the evidence
We won't claim pain relief proves nerve regeneration, or that a nerve-conduction change automatically means better balance or lower ulcer risk.
Treating the cause stays first
Results vary between patients and stem cell therapy is not a guaranteed cure — we set expectations honestly from the start.
Direct answer
What the current evidence says
Neuropathy isn't one disease, so we don't treat it like one. Our physicians identify whether diabetes, a toxin, an immune condition, compression, or a nutritional cause is driving your symptoms, and treat that first. Early cell research — mostly in diabetic neuropathy — hasn't been shown to regenerate nerves outright, and we tell you that clearly. Where a supervised, well-documented cell therapy protocol may support your symptom relief, we explain exactly what to expect. Request your free medical evaluation to get started.
Clinical map
Start with the diagnosis, stage, and treatment context
The highest-value step is identifying reversible and dangerous causes before we discuss any cell therapy.
Established care comes first
- Treat the cause: We help optimize glucose control, replace deficiencies, remove toxins, treat immune disease, or arrange nerve decompression.
- Protect function: Foot care, balance and strength therapy, and ulcer surveillance are part of your ongoing plan.
- Manage symptoms: We select neuropathic-pain medicines and non-drug strategies around your sleep, mood, and kidney function.
- 01
Large-fiber neuropathy
Numbness, weakness, reflex loss, and abnormal nerve-conduction studies define this pattern.
- 02
Small-fiber neuropathy
Burning pain and autonomic symptoms may need skin biopsy or autonomic testing when routine EMG is normal.
- 03
Focal or immune neuropathy
Entrapment, radiculopathy, CIDP, and vasculitis get their own targeted diagnostic and treatment pathway.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 Cell therapy for diabetic peripheral neuropathy
Open source- Product
- Heterogeneous autologous or allogeneic cell preparations
- Route
- Mostly local intramuscular delivery in studied diabetic protocols
- Design
- Systematic review and meta-analysis of small clinical studies
- Finding
- Reported signals in symptoms and physiologic measures warrant further study.
- Limitation
- Small, heterogeneous studies with bias and limited durability do not establish routine efficacy or transfer to other neuropathies.
Product and route
A mechanism is not a clinical outcome
- 01
We match the route to the evidence
Intramuscular delivery studied for diabetic neuropathy doesn't automatically justify an IV infusion or an injection into a nerve, and we're upfront about that.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
Treating the cause stays first
We won't offer a cell product as a substitute for treating diabetes, a deficiency, compression, or infection.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
Neuropathic pain scale
- 02
Strength, gait, balance, and falls
- 03
Sensation and ulcer status
- 04
Nerve-conduction or small-fiber measures when appropriate
- 05
Sleep, function, and medication burden
Specialist review
What a complete Istanbul review needs
Our Istanbul team diagnoses the source of your neuropathy, protects standard care, and offers a carefully monitored cell therapy option where it fits.
Records and baseline
- Neurologic examination and distribution of symptoms
- EMG and nerve-conduction reports or small-fiber testing
- Diabetes, B12, thyroid, kidney, immune, and toxin workup
- Foot wounds, vascular status, falls, and autonomic symptoms
- Product identity, dose, route, and evidence matched to your neuropathy
Safety and planning checks
- Open ulcers, infection, or rapidly progressive weakness get prompt conventional assessment first.
- Your Istanbul review separates neuropathy from radiculopathy and vascular pain before any injection is discussed.
- We keep your diabetes control, foot care, and prescribed treatment active through travel.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- Open ulcers, infection, or rapidly progressive weakness get prompt conventional assessment first.
- Your Istanbul review separates neuropathy from radiculopathy and vascular pain before any injection is discussed.
- We keep your diabetes control, foot care, and prescribed treatment active through travel.
Questions the plan must answer
- 01
We match the route to the evidence: Intramuscular delivery studied for diabetic neuropathy doesn't automatically justify an IV infusion or an injection into a nerve, and we're upfront about that.
- 02
Treating the cause stays first: We won't offer a cell product as a substitute for treating diabetes, a deficiency, compression, or infection.
Primary reading
Guidelines, trials, and regulatory context
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.